Addressing the Zika Virus Threat to the US Blood Supply by NAT
Course Overview
Course Quality Rating
TBD
Course Description
This course is provided by Association of Public Health Laboratories and will require a secondary login and/or registration.
This archived webinar is presented by Jeffrey M. Linnen, PhD, Associate Vice-President, R&D. Hologic Inc., San Diego, CA. In the last year, Zika virus has rapidly spread in South and Central America and could be a real threat to transfusion blood and blood components in the US and its territories. This program will discuss the performance characteristics of an investigational nucleic acid test (NAT) for Zika virus RNA along with an update on NAT blood screening for Zika virus in the US under an Investigational New Drug (IND) protocol. Costs: $25/person includes limited access and CEUs for one person.
Target Audience
This archived webinar is designed for laboratorians.
Learning Objectives
Having completed this archived webinar, the learner will be able to:
- Explain the role of nucleic acid testing in reducing the risk of Zika virus transfusion transmission
Council of Linkages Core Competencies for Public Health Professionals (COL)/COL Tier(s)
None listed
Professional/Disciplinary Competencies
None listed
Format
Archived Webinar
Credit /CEU
Approved for 1.0 P.A.C.E. ®, Florida or CPH-Recertification Credit; CEUs accepted by all licensure states.
Duration
None listed
Specifications
None listed
Course Publication Date
September 22, 2016